Morning Market Movers

Cancer Genetics

shares climbed 28.33% to $7.70 on Q3 results. The company reported a Q3 loss of $0.41 per share on revenue of $3.22 million. ArQule

shares jumped 15.09% to $1.22 after the company reported better-than-expected Q3 results and announced positive top-line results of NIH-sponsored Phase 2 trial of tivantinib in prostate cancer. Dean Foods Company

shares gained 12.45% to $16.22 after the company reported stronger-than-expected results for the third quarter and issued a strong forecast. Vimicro International

shares jumped 7.38% to $9.73 after gaining 1.91% on Friday. Achillion Pharmaceuticals

shares climbed 7.32% to $10.85 after the company reported a 100% SVR12 in a Phase 2 combination study with ACH-3102. China Finance Online Co

shares rose 7.15% to $5.90 after dropping 3.67% on Friday. Orexigen Therapeutics

shares gained 5.45% to $4.06 as the company reported Q3 earnings of $0.09 per share on revenue of $30.86 million. Sotheby's

shares rose 1.57% to $40.06 after the company reported a Q3 loss of $0.40 per share on revenue of $94.20 million.